ED Observation for Opioid Use Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine which approach is more effective for patients with untreated opioid use disorder (OUD) visiting the emergency department: a standard short visit or an extended stay for observation (ED Observation). The extended observation involves staying up to 23 hours, during which additional information about the participant’s health and opioid use is collected. Individuals with a history of non-medical opioid use who are not currently receiving formal addiction treatment might be suitable for this study. The trial takes place at several hospitals, including those within the Northwell Health system. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance emergency care for OUD patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on people not already receiving formal addiction treatment or pain management, so it's best to discuss your specific situation with the trial staff.
What prior data suggests that ED Observation is safe for patients with opioid use disorder?
Research has shown that keeping patients with opioid use disorder (OUD) in the emergency department (ED) for observation can be safe. Studies have examined patient outcomes when they remain in the ED longer for monitoring. These studies suggest that this approach can help ensure patients receive necessary follow-up care.
No specific reports of serious safety issues have emerged with ED observation for OUD patients, indicating it might be well-tolerated. However, it's important to understand that ED observation differs from trying a new medication. It mainly involves staying in the hospital longer for monitoring and support, which usually presents lower risks compared to taking a new drug.
Prospective participants can feel somewhat reassured that ED observation is generally considered safe based on current research.12345Why are researchers excited about this trial?
Researchers are excited about the ED Observation approach for opioid use disorder because it offers a unique method of care in the Emergency Department (ED) setting. Unlike the standard ED visit, which typically lasts 3-5 hours, this approach extends the visit up to 23 hours, allowing more time for observation and assessment. This extended observation period provides a valuable opportunity to gather detailed information on a participant's opioid use, healthcare needs, and overall well-being. Additionally, it enables healthcare providers to collect biological samples like urine or saliva, which can offer deeper insights into the patient's condition and response to treatment. This comprehensive approach could lead to more personalized and effective care strategies for individuals struggling with opioid use disorder.
What evidence suggests that ED Observation is effective for opioid use disorder?
Research has shown that treating opioid use disorder (OUD) in the emergency department observation unit (EDOU) can lead to better health outcomes. In this trial, participants will either have a standard Emergency Department visit or an extended visit with observation in the EDOU. Studies have found that patients with OUD who receive care in an EDOU are more likely to continue treatment and improve their health. For example, starting treatment with buprenorphine, a medication that helps reduce opioid cravings, in the emergency department is both possible and effective for short-term benefits. Another study found that using the EDOU for OUD patients can effectively support their recovery. Overall, these findings suggest that spending more time in the emergency department might help manage OUD better than a standard visit alone.13467
Who Is on the Research Team?
Ryan McCormack, MD
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for adults over 18 who visit the ED with untreated Opioid Use Disorder (OUD), can speak English, and are not currently in formal addiction treatment. They must be willing to receive standard or extended care based on random assignment and have a history of non-medical opioid use.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive standard or extended Emergency Department visits for management of OUD with MOUD
Follow-up
Participants are monitored for engagement in formal addiction treatment and health-related quality of life
What Are the Treatments Tested in This Trial?
Interventions
- ED Observation
ED Observation is already approved in United States for the following indications:
- Opioid Use Disorder (OUD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Institutes of Health (NIH)
Collaborator